Cargando…

Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups

BACKGROUND: Interleukin 6 (IL-6) signaling is being investigated as a therapeutic target for atherosclerotic cardiovascular disease (CVD). While changes in circulating high-sensitivity C-reactive protein (hsCRP) are used as a marker of IL-6 signaling, it is not known whether there is effect heteroge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Georgakis, Marios K., Malik, Rainer, Richardson, Tom G., Howson, Joanna M. M., Anderson, Christopher D., Burgess, Stephen, Hovingh, G. Kees, Dichgans, Martin, Gill, Dipender
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367072/ https://www.ncbi.nlm.nih.gov/pubmed/35948913 http://dx.doi.org/10.1186/s12916-022-02446-6

Ejemplares similares

Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes: A Mendelian Randomization Study
por: Georgakis, Marios K., et al.
Publicado: (2020)

Genetically Predicted Blood Pressure Across the Lifespan: Differential Effects of Mean and Pulse Pressure on Stroke Risk
por: Georgakis, Marios K., et al.
Publicado: (2020)

Genetically Predicted Midlife Blood Pressure and Coronary Artery Disease Risk: Mendelian Randomization Analysis
por: Gill, Dipender, et al.
Publicado: (2020)

Dose–response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus
por: Burgess, Stephen, et al.
Publicado: (2021)

Additive Effects of Genetic Interleukin‐6 Signaling Downregulation and Low‐Density Lipoprotein Cholesterol Lowering on Cardiovascular Disease: A 2×2 Factorial Mendelian Randomization Analysis
por: Georgakis, Marios K., et al.
Publicado: (2021)

Genetically Determined Platelet Count and Risk of Cardiovascular Disease: Mendelian Randomization Study
por: Gill, Dipender, et al.
Publicado: (2018)

Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes
por: Georgakis, Marios K., et al.
Publicado: (2020)

Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses
por: Malik, Rainer, et al.
Publicado: (2021)

Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian Randomization
por: Cupido, Arjen J., et al.
Publicado: (2022)

Modifiable Lifestyle Factors and Risk of Stroke: A Mendelian Randomization Analysis
por: Harshfield, Eric L., et al.
Publicado: (2021)

Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study
por: Cronjé, Héléne T., et al.
Publicado: (2023)

Circulating biomarkers of immunity and inflammation, risk of Alzheimer’s disease, and hippocampal volume: a Mendelian randomization study
por: Fani, Lana, et al.
Publicado: (2021)

Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study
por: Yuan, Shuai, et al.
Publicado: (2021)

Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects
por: Gill, Dipender, et al.
Publicado: (2019)

Mendelian randomization for studying the effects of perturbing drug targets
por: Gill, Dipender, et al.
Publicado: (2021)

Genetically proxied HTRA1 protease activity and circulating levels independently predict risk of ischemic stroke and coronary artery disease
por: Dichgans, Martin, et al.
Publicado: (2023)

Genetic evidence for vitamin D and cardiovascular disease: choice of variants is critical
por: Burgess, Stephen, et al.
Publicado: (2022)

Cardiac Risk Factors for Stroke: A Comprehensive Mendelian Randomization Study
por: Frerich, Simon, et al.
Publicado: (2021)

Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study
por: Georgakis, Marios K., et al.
Publicado: (2021)

Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes
por: Gill, Dipender, et al.
Publicado: (2020)

Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation
por: Hyman, Matthew C., et al.
Publicado: (2021)

Genome‐wide meta‐analysis identifies 3 novel loci associated with stroke
por: Malik, Rainer, et al.
Publicado: (2018)

Dissecting the IL‐6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R
por: Cupido, Arjen J., et al.
Publicado: (2022)

Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis
por: Prapiadou, Savvina, et al.
Publicado: (2023)

The evolution of mendelian randomization for investigating drug effects
por: Gill, Dipender, et al.
Publicado: (2022)

Genetic Evidence for Protective Effects of Angiotensin-Converting Enzyme Against Alzheimer Disease But Not Other Neurodegenerative Diseases in European Populations
por: Ryan, David K., et al.
Publicado: (2022)

Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors
por: Pećin, Ivan, et al.
Publicado: (2017)

Low‐Density Lipoprotein Cholesterol Attributable Cardiovascular Disease Risk Is Sex Specific
por: Cupido, Arjen J., et al.
Publicado: (2022)

Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke
por: Abraham, Gad, et al.
Publicado: (2019)

Author Correction: Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke
por: Abraham, Gad, et al.
Publicado: (2020)

Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy
por: Kraaijenhof, Jordan M., et al.
Publicado: (2023)

Genetically Predicted Type 2 Diabetes Mellitus Liability, Glycated Hemoglobin and Cardiovascular Diseases: A Wide-Angled Mendelian Randomization Study
por: Liu, Bowen, et al.
Publicado: (2021)

Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling
por: Karhunen, Ville, et al.
Publicado: (2021)

Genetic Liability to Depression and Risk of Coronary Artery Disease, Myocardial Infarction, and Other Cardiovascular Outcomes
por: Lu, Yunlong, et al.
Publicado: (2020)

Systemic iron status and maternal pregnancy complications: A Mendelian randomization study
por: Rogne, Tormod, et al.
Publicado: (2022)

Treatment of severe covid-19 with interleukin 6 receptor inhibition
por: Rajasundaram, Skanda, et al.
Publicado: (2022)

Interactions Between Kidney Function and Cerebrovascular Disease: Vessel Pathology That Fires Together Wires Together
por: Marini, Sandro, et al.
Publicado: (2021)

A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits
por: Foley, Christopher N., et al.
Publicado: (2021)

Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia
por: Larsson, Susanna C., et al.
Publicado: (2021)

Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease
por: Levin, Michael G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_656fke27h82rj3k1ek479st02m